Select Page
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Development & Bioavailability
  6.  » Optimizing Small Batch Size To Solve Formulation Challenges

Optimizing Small Batch Size To Solve Formulation Challenges

Summary: It is common to have a limited amount of API in the early phase of drug development, which impedes the rapid progression of drug development. Catalent has developed a new approach that enables the use of industrial scale machines from the very beginning and can result in manufacturing cGMP batches with good yields.

Click here to download technical note.